Sierra Oncology (SRRA) Downgraded by Zacks Investment Research

Retrieved on: 2018-10-22 12:52:30

Tags for this article:

Click the tags to see associated articles and topics

Sierra Oncology (SRRA) Downgraded by Zacks Investment Research. View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc acquired a new position in shares of Sierra Oncology during the 1st quarter worth about $203,000. Finally, Fred Alger ...</div>

Article found on:

View Original Article